Screener
Kestra Medical Technologies KMTS EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Kestra Medical Technologies’s reported figures.
Based on trailing twelve months.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026. Open the filing →
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
FAQ
- What is Kestra Medical Technologies's EBITDA margin?
- Kestra Medical Technologies (KMTS) reported EBITDA margin of -132.5% in Q1 2026.
- How has Kestra Medical Technologies's EBITDA margin changed year-over-year?
- Kestra Medical Technologies's EBITDA margin increased by 19.5% year-over-year, from -164.5% to -132.5%.
- What is the long-term trend for Kestra Medical Technologies's EBITDA margin?
- Over 2 years (2024 to 2026), Kestra Medical Technologies's EBITDA margin has grown at a -29.2% compound annual growth rate (CAGR), from -264.3% to -132.5%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Kestra Medical Technologies's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude